Bleakley Financial Group’s Capital Group Dividend Value ETF CGDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.1M Buy
204,899
+84,590
+70% +$3.98M 0.13% 126
2026
Q1
$5.12M Buy
120,309
+10,041
+9% +$446K 0.08% 208
2025
Q4
$4.81M Buy
110,268
+1,347
+1% +$57.8K 0.08% 191
2025
Q3
$4.58M Buy
108,921
+5,504
+5% +$226K 0.11% 167
2025
Q2
$4.08M Buy
103,417
+3,598
+4% +$130K 0.1% 177
2025
Q1
$3.56M Sell
99,819
-775
-0.8% -$28.1K 0.11% 164
2024
Q4
$3.55M Buy
100,594
+464
+0.5% +$16.9K 0.11% 164
2024
Q3
$3.65M Buy
100,130
+1,936
+2% +$67.2K 0.11% 158
2024
Q2
$3.24M Buy
98,194
+2,554
+3% +$83.2K 0.09% 198
2024
Q1
$3.11M Buy
95,640
+7,512
+9% +$231K 0.09% 211
2023
Q4
$2.63M Buy
88,128
+13,428
+18% +$370K 0.08% 224
2023
Q3
$1.98M Buy
74,700
+2,322
+3% +$63.5K 0.07% 263
2023
Q2
$1.96M Buy
+72,378
New +$1.86M 0.06% 275

Other funds holding CGDV

Bleakley Financial Group's CGDV Position: Q2 2026 in Review

Bleakley Financial Group increased its Capital Group Dividend Value ETF (CGDV) stake by 70% in Q2 2026, buying an estimated $3.98M and bringing the position to 204,899 shares worth $10.1M. The position accounts for 0.13% of the portfolio, ranked #126.

Bleakley Financial Group first reported a position in CGDV in Q2 2023 and has held it in 13 quarters since. 533 funds tracked by Wall St. Rank hold CGDV as of Q2 2026.

  • Bleakley Financial Group held 204,899 shares of Capital Group Dividend Value ETF worth $10.1M as of Q2 2026.
  • Bleakley Financial Group bought 84,590 Capital Group Dividend Value ETF shares in Q2 2026, an estimated $3.98M.
  • Capital Group Dividend Value ETF made up 0.13% of Bleakley Financial Group's portfolio in Q2 2026, its #126 holding.
  • Bleakley Financial Group first reported a position in Capital Group Dividend Value ETF in Q2 2023 and has held it in 13 quarters since.
  • 533 funds tracked by Wall St. Rank held Capital Group Dividend Value ETF as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.